newsfilter
← Latest News
Business Wire·

OS Therapies Announces Pricing of $6 Million Private Placement

Funding will provide Company sufficient cash runway into 2026 95% of investment in private placement from Pre-IPO and/or IPO investors Data from OST-HER2 Phase 2b in recurrent, resected metastatic osteosarcoma to